The third phase of the study of the vaccine center "Vector" can begin in October

“The start date of the third stage will depend on the timing of obtaining a marketing authorization for the EpiVacCorona vaccine.

Tentatively at the end of October, ”they said.

Earlier, the Minister of Industry and Trade of Russia Denis Manturov said that the Biocad company would be engaged in the production of the second Russian vaccine against coronavirus infection. 

According to the minister, the enterprise was "in full contact" with the Vector, a center for virology and biotechnology, which is developing a vaccine.